Eruption of palmoplantar pustular psoriasis in patient treated with anti-androgen therapy for prostate cancer and aggravation of lesions after statin treatment

Central European Journal of Medicine

Volumn 9, Issue 5, 2014, Pages 657-662

  Pietrzak, Aldona ^a   Mosiewicz, Jerzy ^a   Chodorowska, Grazyna ^a   Brzozowska, Anna ^a,b   Michalak Stoma, Anna ^a   Szumiło, Justyna ^a,b   Trojnar, Marcin ^a   Krasowska, Dorota ^a   Wawrzycki, Bartłomiej ^a   Franciszkiewicz Pietrzak, Kinga ^a   Polkowski, Wojciech ^a   Lotti, Torello ^c  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b St John's Cancer Centre   (Poland)

^c Department of Oncology Medical University of Lublin ^*  (Italy)

Author keywords

Hormone therapy; Prostate cancer; Psoriasis; Statin

Indexed keywords

ASCORBIC ACID; BICALUTAMIDE; BISPHOSPHONIC ACID DERIVATIVE; CLEMASTINE; DESLORATADINE; FEXOFENADINE; FLUTAMIDE; GLICLAZIDE; GLUCOSE; GOSERELIN; LONG ACTING INSULIN; NICOTINAMIDE; PAMIDRONIC ACID; RUTOSIDE; SALICYLIC ACID; SIMVASTATIN; STEROID; TRIPTORELIN;

ADULT; ARTICLE; BONE METASTASIS; CANCER HORMONE THERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE COURSE; DISEASE DURATION; DRUG WITHDRAWAL; ERYTHEMA; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PUSTULE; PUSTULOSIS PALMOPLANTARIS; RADIATION DOSE; SKIN DEFECT; ULTRAVIOLET A RADIATION;

EID: 84905508144     PISSN: 18951058     EISSN: 16443640     Source Type: Journal    
DOI: 10.2478/s11536-013-0310-2     Document Type: Article

References (27)

1. Paul CF, Ho VC, McGeown C, et al. Risk of Malignancies in Psoriasis Patients Treated with Cyclosporine: a 5 y Cohort Study. J Invest Dermatol. 2003;120:211-216 (Pubitemid 36513069)
2. Margolis D, Bilker W, Hennessy S, Vittorio C, Santanna J, Strom BL. The risk of malignancy associated with psoriasis. Arch Dermatol. 2001;137:778-783 (Pubitemid 32577862)
3. Labrie F, Dupont A, Belanger A, et al. New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens. Prostate. 1983;4:579-594 (Pubitemid 14243323)
4. Meng J, Mostaghel EA, Vakar-Lopez F, Montgomery B, True L, Nelson PS. Testosterone regulates tight junction proteins and influences prostatic autoimmune responses. Horm Cancer. 2011;2:145-156
5. Muehlenbein MP, Bribiescas RG. Testosterone-mediated immune functions and male life histories. Am J Hum Biol. 2005;17:527-558 (Pubitemid 41684269)
6. Bouman A, Heineman MJ, Faas MM. Sex hormones and the immune response in humans. Hum Reprod Update. 2005;11:411-423 (Pubitemid 40895468)
7. Fitzpatrick F, Lepault F, Homo-Delarche F, Bach JF, Dardenne M. Influence of castration, alone or combined with thymectomy, on the development of diabetes in the nonobese diabetic mouse. Endocrinology. 1991;129:1382-1390
8. Harbuz MS, Perveen-Gill Z, Lightman SL, Jessop DS. A protective role for testosterone in adjuvant-induced arthritis. Br J Rheumatol. 1995;34:1117-1122 (Pubitemid 26055330)
9. Ahmed SA, Penhale WJ. The influence of testosterone on the development of autoimmune thyroiditis in thymectomized and irradiated rats. Clin Exp Immunol. 1982;48:367-374 (Pubitemid 12113088)
10. Fox HS. Androgen treatment prevents diabetes in nonobese diabetic mice. J Exp Med. 1992;175:1409-1412
11. Dalal M, Kim S, Voskuhl RR. Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in theautoantigen-specific T lymphocyte response. J Immunol. 1997;159:3-6 (Pubitemid 127493678)
12. Ansar Ahmed S, Young PR, Penhale WJ. Beneficial effect of testosterone in the treatment of chronic autoimmune thyroiditis in rats. J Immunol. 1986;136:143-147 (Pubitemid 16232163)
13. Drake CG. Prostate cancer as a model for tumour immunotherapy. Nat Rev Immunol. 2010;10:580-593
14. Morse MD, McNeel DG. Prostate cancer patients on androgen deprivation therapy develop persistent changes in adaptive immune responses. Hum Immunol. 2010;71:496-504
15. Norata GD, Cattaneo P, Poletti A, Catapano AL. The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits tumor necrosis factor alpha and lipopolysaccharide induced inflammatory response in human endothelial cells and in mice aorta. Atherosclerosis. 2010;212:100-106
16. Norata GD, Tibolla G, Seccomandi PM, Poletti A, Catapano AL. Dihydrotestosterone decreases tumor necrosis factor-alpha and lipopolysaccharideinduced inflammatory response in human endothelial cells. J Clin Endocrinol Metab. 2006;91:546-554 (Pubitemid 43236925)
17. Kalinchenko SY, Tishova YA, Mskhalaya GJ, Gooren LJ, Giltay EJ, Saad F. Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study. Clin Endocrinol (Oxf). 2010;73:602-612
18. Komatsu S, Hara N, Ishizaki F, Nishiyama T, Takizawa I, Isahaya E, Kawasaki T, Takahashi K. Altered association of interleukin-6 with sex steroids in lipid metabolism disorder in men with prostate cancer receiving androgen deprivation therapy. Prostate. 2012;72:1207-1213
19. Kolvenbag GJ, Furr BJ, Blackledge GR. Receptor affinity and potency of non-steroidal antiandrogens: translation of preclinical findings into clinical activity. Prostate Cancer Prostatic Dis. 1998;1:307-314 (Pubitemid 128545880)
20. Ziółkowska E, Biedka M, Żyromska A, Makarewicz R. Psoriasis exacerbation after hormonotherapy in prostate cancer patient - Case report. Rep Pract Oncol Radiother. 2010;15:103-106
21. Honma M, Takahashi H, Horikawa M, Iizuka H. Palmoplantar Pustular Lesions during Ovulation Inducement Therapy: New Insight into the Pathomechanism of Palmoplantar Pustulosis? Dermatology. 2009;218:382-384
22. Egesi A, Sun G, Khachemoune A, Rashid RM. Statins in skin: research and rediscovery, from psoriasis to sclerosis. J Drugs Dermatol. 2010;9:921-927
23. Rajpara AN, Goldner R, Gaspari A. Psoriasis: can statins play a dual role? Dermatol Online J. 2010;16:2
24. Shirinsky IV, Shirinsky VS. Efficacy of simvastatin in plaque psoriasis: A pilot study. J Am Acad Dermatol. 2007;57:529-531 (Pubitemid 47239149)
25. Fisher DA, Elias PM, LeBoit PL. Exacerbation of psoriasis by the hypolipidemic agent, gemfibrozil. Arch Dermatol. 1988;124:854-855
26. Cozzani E, Scaparro M, Parodi A. A case of psoriasis worsened by atorvastatin. J Dermatol Case Rep. 2009;3:60-61
27. Jacobi TC, Highet A. A clinical dilemma while treating hypercholesterolaemia in psoriasis. Br J Dermatol. 2003;149:1305-1306 (Pubitemid 38058120)